Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
World Market Indices Sample List offers a practical snapshot of representative indices across regions, helping with broad market framing.
28,364 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Y Combinator will conduct crypto-focused startup interviews in New York for the first time, highlighting NYC's growin...
Palantir Technologies presents a paradox: strong fundamentals on one hand, a volatile stock on the other. This articl...
Ripple has lined up a wave of partnerships with global banks in 2026, but XRP prices haven’t reflected the wins. Here...
NVIDIA just raised dividend marks a bold shift in capital allocation as AI demand surges. This guide breaks down what...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
A veteran software developer weighs early retirement as AI reshapes the field. With a paid-off home and a sizable por...
The centenarian economist who invented fed’s magic trick dies at 100. His successor now weighs reviving the policy pl...
An accessible analysis of what this $405,000 bj's insider sale means for investors, plus practical steps to read insi...
A new, Lubin-backed nonprofit launches to accelerate institutional adoption of Ethereum and its Layer 2 ecosystem. Th...
Schwab strategists warn major shifts are underway as volatility rises and policy tightens, signaling an era change fo...